Molecular genetics and metabolism · 2025
Identification of variants of the MTR gene in patients with the cblG inborn error of cobalamin metabolism diagnosed by somatic cell complementation analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Watkins David, Zacharias Caitlin, Arbabian-Urquilla Kyana, Ragupathi Krithika, Gilfix Brian M, Jimenez Daniel, Anastasio Natascia, Rivière Jean-Baptiste, Rosenblatt David S
Аннотация
PURPOSE: The cblG inborn error of vitamin B12 metabolism is associated with pathogenic variants in the MTR gene, which encodes methionine synthase. Approximately 50 patients with the disorder have been reported, and 54 potentially causal MTR variants published.
METHODS: We performed next generation sequencing and copy number variant analysis of MTR on genomic DNA from 29 cblG patients, including 7 patients that had been previously sequenced with incomplete results. All patients had been diagnosed using somatic cell complementation analysis.
RESULTS: We identified two potential causal variants in each of the patients analyzed, although parental phasing was not done. 39 different variants were identified, including 24 not previously described in the published literature. The most common identified causal variant was c.3518C > T, p.P1173L (8 alleles). The previously identified deep intronic variants c.340-166 A > T and c.609 + 1088G > A were also seen frequently (6 alleles each). Among the newly identified variants, the most common were c.2020C > T p.Arg674Cys (3 alleles) and c.1325C > A, p.Ala442Glu (2 alleles).
CONCLUSION: Identification of pathogenic or likely pathogenic variants was enhanced by knowledge of complementation status which has become less frequent as somatic cell testing becomes less readily available.
METHODS: We performed next generation sequencing and copy number variant analysis of MTR on genomic DNA from 29 cblG patients, including 7 patients that had been previously sequenced with incomplete results. All patients had been diagnosed using somatic cell complementation analysis.
RESULTS: We identified two potential causal variants in each of the patients analyzed, although parental phasing was not done. 39 different variants were identified, including 24 not previously described in the published literature. The most common identified causal variant was c.3518C > T, p.P1173L (8 alleles). The previously identified deep intronic variants c.340-166 A > T and c.609 + 1088G > A were also seen frequently (6 alleles each). Among the newly identified variants, the most common were c.2020C > T p.Arg674Cys (3 alleles) and c.1325C > A, p.Ala442Glu (2 alleles).
CONCLUSION: Identification of pathogenic or likely pathogenic variants was enhanced by knowledge of complementation status which has become less frequent as somatic cell testing becomes less readily available.